| Price and Chart delayed at least 15 mintues. |
|
Price
$ 49.70
|
Change
0.00
|
|
Open
0.00
|
% Change
0.0%
|
|
Prev Close
49.70
|
Volume
NA
|
|
Market Value
44 bil
|
P/E Ratio
47.3
|
|
Bid
49.00
|
EPS
1.05
|
|
Ask
49.69
|
Dividend
0.43
|
|
High
0.00
|
Yield
0.9
|
|
Low
0.00
|
Shares Out
891 mil
|
|
52wk High
50.35
|
52wk Low
35.89
|
|
Industry: Drug Manufacturers - Other
|
|
Sector: Healthcare
|
TEVA Profile
A global pharmaceutical company, which develops, produces and markets generic drugs covering all major treatment categories.
Teva Pharmaceutical Ltd.
5 Basel Street
P.O. Box 3190 Petach Tikva, 49131
Phone: 97239267267
Fax: 97239234050
Web Site: www.tevapharm.com
TEVA Wires Headlines
|
|
| 07.01.09 |
|
Teva launches version of JNJ birth control pill
|
|
| 07.01.09 |
|
BRIEF-Teva says FDA approves Tri-Lo Sprintec oral contraceptive
|
|
| 06.30.09 |
|
Teva, biotech firm partner to make cancer drugs work
|
|
| 06.29.09 |
|
Teva, Antares get FDA OK for hormone in new device
|
|
| 06.29.09 |
|
UPDATE 2-Teva, Antares get FDA nod for needle-free device
|
More TEVA From Wires Headlines >
Forbes.com on TEVA RSS
|
|
|
Teva Pharmaceutical Inds is ranked # 381 on the 2009 Forbes 2000 List
|
|
Thomson / IBES Earnings Estimates on TEVA
Accounting Risk
Buy/Hold/Sell Analysis
Forbes Investment Guru Commentary on TEVA
RSS News Feed on TEVA
|
A D V E R T I S E M E N T
|